Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiko Tomino

Showing results (1-10 of 318) with videos related to

Pageof 32
Sort By:
Clinical and Experimental Nephrology|November 9, 2010
Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouseYasuhiko Tomino
Nephrology (Carlton, Vic.)|April 10, 2010
Spontaneous animal model, ddY mouse, for studying the pathogenesis and treatment in patients with immunoglobulin A nephropathyYasuhiko Tomino
Nephro-Urology Monthly|April 11, 2013
Lessons From the KK-Ay Mouse, a Spontaneous Animal Model for the Treatment of Human Type 2 Diabetic NephropathyYasuhiko Tomino
Kidney Research and Clinical Practice|December 14, 2016
Diagnosis and treatment of patients with IgA nephropathy in JapanYasuhiko Tomino
The Kaohsiung Journal of Medical Sciences|October 24, 2012
Predictors of prognosis in IgA nephropathyYasuhiko Tomino
Current Hypertension Reviews|August 27, 2013
Renoprotective effects of the L-/T-type calcium channel blocker benidipine in patients with hypertensionYasuhiko Tomino
Kidney & Blood Pressure Research|December 16, 2014
Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical dataYasuhiko Tomino
Nephrology (Carlton, Vic.)|October 10, 2018
How to treat patients with chronic kidney disease: With special focus on IgA nephropathyYasuhiko Tomino
Clinical and Experimental Nephrology|September 22, 2011
Mechanisms and interventions in peritoneal fibrosisYasuhiko Tomino
Contributions to Nephrology|May 22, 2013
Immunopathological predictors of prognosis in IgA nephropathyYasuhiko Tomino
Pageof 32

Showing results (1-10 of 318) with videos related to

Sort By:
Pageof 32
Clinical and Experimental Nephrology|November 9, 2010
Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouseYasuhiko Tomino
Nephrology (Carlton, Vic.)|April 10, 2010
Spontaneous animal model, ddY mouse, for studying the pathogenesis and treatment in patients with immunoglobulin A nephropathyYasuhiko Tomino
Nephro-Urology Monthly|April 11, 2013
Lessons From the KK-Ay Mouse, a Spontaneous Animal Model for the Treatment of Human Type 2 Diabetic NephropathyYasuhiko Tomino
Kidney Research and Clinical Practice|December 14, 2016
Diagnosis and treatment of patients with IgA nephropathy in JapanYasuhiko Tomino
The Kaohsiung Journal of Medical Sciences|October 24, 2012
Predictors of prognosis in IgA nephropathyYasuhiko Tomino
Current Hypertension Reviews|August 27, 2013
Renoprotective effects of the L-/T-type calcium channel blocker benidipine in patients with hypertensionYasuhiko Tomino
Kidney & Blood Pressure Research|December 16, 2014
Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical dataYasuhiko Tomino
Nephrology (Carlton, Vic.)|October 10, 2018
How to treat patients with chronic kidney disease: With special focus on IgA nephropathyYasuhiko Tomino
Clinical and Experimental Nephrology|September 22, 2011
Mechanisms and interventions in peritoneal fibrosisYasuhiko Tomino
Contributions to Nephrology|May 22, 2013
Immunopathological predictors of prognosis in IgA nephropathyYasuhiko Tomino
Pageof 32